Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious ...

The following is a summary of “A real-world pharmacovigilance assessment and literature review of lymphoma development in ...

enhances signaling pathways such as PDGFRB-STAT5 or T cell receptor-associated mechanisms. These changes are suspected of promoting the development and spread of lymphomas. "Although the chances ...

The findings suggest assessment of CD20 may be an important factor in determining treatment options in B-cell lymphomas.

A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene ...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...

InnoCare gets China NMPA approval for Minjuvi in combo with lenalidomide to treat relapsed or refractory diffuse large B-cell lymphoma: Beijing, China Friday, May 23, 2025, 13:00 ...

The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which incl ...

DelveInsight’s Marginal Zone Lymphoma pipeline report depicts a robust space with 50+ active players working to develop 50+ ...

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) ...

Most clinical trials test new treatments only after cancer has relapsed and grown large enough to be detected on scans. The ...